Novartis wins injunction to stop generic version of blockbuster MS drug, for now

Intellectual Property 2021-04-12 2:51 pm | Sydney
Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.
For information on rights and reprints, contact subscriptions@lawyerly.com.au